Filter browse results

This publication presents highlights from the 20-year story of PATH and its partners who developed, validated, and are introducing SILCS—the first new diaphragm in 50 years. Marketed by Kessel medintim GmbH as the Caya® contoured diaphragm—SILCS is expanding women’s options for nonhormonal contraception in developed and developing countries.

Part of the Technology Updates series, this fact sheet describes PATH's work, in collaboration with MSR® Global Health, to develop the SE-Flow, an innovative onsite chlorine generator for drinking water treatment and infection prevention and control.

Soil-transmitted helminths (STHs) remain a massive global health problem. More robust, simple, and sensitive diagnostic tools will improve the ability of control programs to determine infection and response procedures. This document illustrates PATH’s contributions toward creating a business case for financing, developing, and deploying new diagnostics for detection of STH infection.

This seven-piece series of purchasing guides is intended to aid procurers in the selection of maternal and neonatal health technologies including birthing and cesarean section simulators, continuous positive airway pressure, fetal monitors, portable ultrasound, rechargeable lighting, thermoregulation devices, and weight scales. Each guide reviews the technology and considers qualities important for use in low-resource settings.

This report presents the results of a video application of The Narrative Project framework to build support for maternal and child health. The project was spearheaded by the Visual Epidemiology Project at Yale University and PATH, in partnership with the New Venture Fund, Bill & Melinda Gates Foundation, World Vision, and Save the Children Action Network. Key findings reveal the effectiveness of an emotional storytelling video approach.

PATH's 2015 annual report celebrates significant PATH milestones across four key areas: malaria, vaccines and immunization, women's and girls' health, and nutrition and child health. From important advances in malaria control and elimination to new contraceptive options reaching women who have never before used modern family planning methods, these achievements underscore PATH's leadership in global health innovation. Together with our more than 2,000 partner organizations, PATH has reached an average of 150 million people per year since 2011 with sustainable health solutions like these.

The Healthy Household Initiative seeks to increase the accessibility, affordability, and use of health products by low-resource families through strengthened supply chains and innovative financing mechanisms. Results from this initiative implemented in India and Honduras are shared in this presentation.

The messages within this document can be used by advocates, program implementers, and others who seek to promote increased access to and availability of affordable, quality-assured medicines, technologies and other health supplies for reproductive, maternal, newborn, child and adolescent health.

More than 150 leading global health and development thinkers convened on June 15, 2016, for The Innovation Effect: Powering Disruptive Global Health Solutions in Washington, DC. This conference report provides an overview of the insights shared when attendees explored what happens when unique partnerships, disruptive technologies, transformed systems, and data-driven insights combine in often unexpected ways to create dramatic improvements in the health and well-being of people around the world.

This guide is designed to help country decision-makers understand the evidence around Japanese encephalitis (JE) vaccine introduction, the potential benefits, and how to incorporate JE vaccines into their country’s immunization program. The guide consists of five modules, including:

1. Does My Country Need JE Vaccine?2. Is JE Vaccination Cost Effective?3. Which JE Vaccine Should My Country Use?4. How Should My Country Introduce JE Vaccine?5. Can My Country Afford a JE Vaccination Program?

This fact sheet describes PATH’s work to increase access to oxygen therapy for the treatment of life-threatening pneumonia and hypoxemia in newborns and children. Facilitating inclusion of expanded uses of oxygen on the World Health Organization’s Essential Medicines List, as well as the inclusion of oxygen technologies and pulse oximetry in global commodity lists and treatment guidelines, are essential for reducing child mortality.

The goal of the Sanitation Service Delivery (SSD) project is to improve urban sanitation outcomes through developing scalable, market-based models that contribute to structural change within the region’s sanitation sector. A summary of gaps identified along the sanitation service chain from product scans completed in Benin, Cote d’Ivoire, and Ghana are included in this brief. A French version of the brief is also available.

This fact sheet highlights PATH’s work to address rotavirus, the leading cause of severe diarrheal disease. It includes general information about our efforts to increase access to and effectiveness of existing vaccines, as well as to develop new vaccines and to raise awareness through advocacy.

In 2014, PATH conducted interviews with stakeholders in Senegal and Uganda to assess receptivity to self-injection of subcutaneous contraceptive Sayana Press as well as the evidence requirements and processes necessary to chart a course for adoption, introduction, and scale-up of self-injection as a service-delivery practice in the two countries.

PATH’s advocacy work builds on and continues global efforts to expand access to simple, essential, and affordable medicines, medical devices, and other health supplies to prevent deaths of women and children worldwide.

Pregnant women in low- and middle-income countries have inadequate access to lifesaving maternal health products, resulting in preventable deaths when complications arise during pregnancy or childbirth. Healthy markets are essential to improving access to these products. This series of advocacy papers provides specific and actionable recommendations that advocates and decision-makers—globally and in three target countries: Bangladesh, Ethiopia, and Nigeria—can use to raise awareness of the urgent actions needed and push for positive policy change to improve the quality and availability of essential maternal health products.

This fact sheet describes a project that PATH is implementing in Vietnam with support from the Biomedical Advanced Research and Development Authority within the US Department of Health and Human Services. The project is supporting the enhancement of sustainable influenza vaccine production in Vietnam. PATH is providing technical assistance to various groups in Vietnam to facilitate the production and clinical evaluation of safe and effective influenza vaccines and synergizing activities with work already under way in Vietnam through the World Health Organization.